Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

CTS Corporation (CTS) SEC Filings & Earnings Calls

EquiReason read 19 CTS Corporation SEC filings in the last 12 months. Latest: SC 13D/A on 2026-08-05 — Gabelli-related entities filed a Schedule 13D disclosing a 5.75% passive stake in CTS Corp, with no activist intent and recent small sales..

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CTSCTS CorporationFollow CTS — free
Electronic Components · Technology
—
Price chart with a free account
Market cap
1.5B
P/E TTM
22.3
Dividend yield
0.3%
52-week
—
Next earnings
27 Oct, in 3 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

5 Aug 2026SC 13D/AGabelli-related entities filed a Schedule 13D disclosing a 5.75% passive stake in CTS Corp, with no activist intent and recent small sales.open

Figures in the filing · each found in the filing text

Beneficial ownership percentage · 2026-08-045.8%
Read the original on SEC EDGAR ↗
5 Aug 2026SC 13D/AGabelli-related entities filed a Schedule 13D disclosing a 5.75% passive stake in CTS Corp, with no activist intent and recent small sales.open

Figures in the filing · each found in the filing text

Beneficial ownership percentage · 2026-08-045.8%
Read the original on SEC EDGAR ↗
28 Jul 20268-K · 7.01LTM Revenue $564M; LTM Adj. EBITDA Margin 24; LTM Adj. Diluted EPS $2.58open

Figures in the filing · each found in the filing text

LTM Revenue · LTM$564M
LTM Adj. EBITDA Margin · LTM24.0%
LTM Adj. Diluted EPS · LTM$2.58

Risks flagged

No new risks identified; presentation contains forward-looking statements with standard cautionary language.

“Cautionary statement regarding forward-looking statements.” · word for word
Read the original on SEC EDGAR ↗
28 Jul 202610-QCTS Corporation reported solid Q2 2026 results with revenue up 7% YoY, gross margin expansion of 270 bps, and EPS growth of 8.1%, driven by strong Medical and Industrial segment performance.earningsopen

Figures in the filing · each found in the filing text

Net Sales · Q2-2026$145M+7% y/y
Net Sales - Transportation · Transportation · Q2-2026$59M-2% y/y
Net Sales - Industrial · Industrial · Q2-2026$40M+16% y/y
Net Sales - Medical · Medical · Q2-2026$28M+45% y/y
Net Sales - Aerospace & Defense · Aerospace & Defense · Q2-2026$18M-15% y/y
Net Earnings · Q2-2026$19M+3% y/y
Operating Cash Flow · H1-2026$51M+16% y/y

Risks flagged

Environmental Remediation Liability

“Remediation reserves of $16.5M as of June 30, 2026, including $6.7M for the Asheville Site settlement.”

Geographic Concentration Risk

“The company has significant international operations, with foreign currency translation adjustments of ($3.3M) in H1 2026.”

Restructuring Risk

“Restructuring charges of $480K in H1 2026 for workforce reduction and facility consolidation.”
Read the original on SEC EDGAR ↗
28 Jul 20268-K · 2.02, 7.01Sales $145M (+7% y/y); Net income $19M (+4% y/y); Diluted EPS $0.66 (+6% y/y); Guidance: Sales guidance raised to $565-585M; adjusted EPS guidance raised to $2.55-$2.70earningsopen

Figures in the filing · each found in the filing text

Sales · Q2-2026$145M+7% y/y
Net income · Q2-2026$19M+4% y/y
Diluted EPS · Q2-2026$0.66+6% y/y
Adjusted Gross margin · Q2-202641.5%
Adjusted EBITDA margin · Q2-202625.4%
Adjusted diluted EPS · Q2-2026$0.74+30% y/y
Operating cash flow · Q2-2026$33M+18% y/y

Guidance

Sales guidance raised to $565-585M; adjusted EPS guidance raised to $2.55-$2.70

Raised guidance on strong diversification and margin performance.

Risks flagged

Transportation market decline of 2% YoY; reliance on diversified markets for growth.

“Sales to the transportation market decreased 2%.” · word for word
Read the original on SEC EDGAR ↗
25 Jun 20268-K · 5.02New CEO base salary $675,000.00; new CEO LTI award $2M; Executive Chairman base salary $625,000.00open

Figures in the filing · each found in the filing text

new CEO base salary · FY2026$675000.00
new CEO LTI award · FY2026$2M
Executive Chairman base salary · FY2026$625000.00

Risks flagged

Leadership transition risk is low due to internal promotion and continued involvement of former CEO.

“New CEO was COO since Dec 2025; outgoing CEO remains Executive Chairman.”
Read the original on SEC EDGAR ↗
29 Apr 20268-K · 2.02, 7.01Sales $139M (+11% y/y); Net income $17M (+31% y/y); Diluted EPS $0.59 (+34% y/y); Guidance: Sales midpoint raised from $565M to $570M; adjusted EPS midpoint raised from $2.375 to $2.40earningsopen

Figures in the filing · each found in the filing text

Sales · total · Q1-2026$139M+11% y/y
Net income · total · Q1-2026$17M+31% y/y
Diluted EPS · total · Q1-2026$0.59+34% y/y
Adjusted gross margin · total · Q1-202639.5%
Adjusted EBITDA margin · total · Q1-202623.0%
Adjusted diluted EPS · total · Q1-2026$0.62+41% y/y
Operating cash flow · total · Q1-2026$17M+12% y/y

Guidance

Sales midpoint raised from $565M to $570M; adjusted EPS midpoint raised from $2.375 to $2.40

CTS narrowed guidance upward, reflecting confidence in continued strong demand and margin expansion.

Risks flagged

Transportation market growth remains modest at 3%, indicating potential cyclical risk.

“Sales to the transportation market increased 3%.” · word for word

Forward-looking statements contain standard macroeconomic and operational risks; no new specific risks identified.

“Generic cautionary language; no company-specific risk updates.”
Read the original on SEC EDGAR ↗
29 Apr 202610-QNet sales $139M (+11% y/y); Net earnings $17M (+29% y/y); Operating cash flow $17M (+12% y/y)open

Figures in the filing · each found in the filing text

Net sales · Q1-2026$139M+11% y/y
Net earnings · Q1-2026$17M+29% y/y
Operating cash flow · Q1-2026$17M+12% y/y
Transportation revenue · Transportation · Q1-2026$60M+3% y/y
Industrial revenue · Industrial · Q1-2026$37M+15% y/y
Medical revenue · Medical · Q1-2026$25M+28% y/y
Aerospace & Defense revenue · Aerospace & Defense · Q1-2026$17M+11% y/y
Read the original on SEC EDGAR ↗
29 Apr 20268-K · 7.01LTM Revenue $555M; LTM Adj. EBITDA Margin 23; LTM Adj. Diluted EPS $2.41open

Figures in the filing · each found in the filing text

LTM Revenue · LTM Q1-2026$555M
LTM Adj. EBITDA Margin · LTM Q1-202623.0%
LTM Adj. Diluted EPS · LTM Q1-2026$2.41

Risks flagged

No new risk signals; presentation contains standard forward-looking cautionary language.

“Cautionary statement regarding forward-looking statements; no specific new risks.”
Read the original on SEC EDGAR ↗
2 Apr 2026DEF 14AAnnual proxy statement disclosing executive compensation, governance, and 2025 financial results.open

Figures in the filing · each found in the filing text

Revenue · FY2025$541M+5% y/y
Operating Cash Flow · FY2025$102M
Medical Segment Sales · Medical · FY2025$85M+21% y/y
Aerospace & Defense Segment Sales · Aerospace & Defense · FY2025$83M+20% y/y
Industrial Segment Sales · Industrial · FY2025$140M+12% y/y
Transportation Segment Sales · Transportation · FY2025$234M-7% y/y
Total Booked Business · FY2025$1.00B
Shareholder Returns · FY2025$62M
Adjusted Diluted EPS · FY2025$2.23+5% y/y
Net Income · FY2025$64M+10% y/y

Risks flagged

Transportation Market Cyclicality

“Transportation sales were $234 million, down 7% compared to 2024, reflecting softer market conditions.” · word for word

Macroeconomic Uncertainty

“Despite mixed macroeconomic conditions, our teams executed well” · word for word

Supply Chain Disruption

“supply chain disruptions (including, but not limited to, the availability and cost of rare earth elements, minerals and metals)” · word for word
Read the original on SEC EDGAR ↗
24 Feb 202610-KRisks named: Tariff and trade policy uncertainty, Rare earth supply dependency on China, Cyclical end-market exposure, Defense contract vulnerabilityopen

Risks flagged

Tariff and trade policy uncertainty

“During 2025, there were significant changes to tariffs by the U.S. and other countries.” · word for word

Rare earth supply dependency on China

“China is a predominant producer of these materials. China has in the past restricted export of certain of these materials.” · word for word

Cyclical end-market exposure

“We sell products to customers in cyclical industries that have experienced economic and industry downturns.” · word for word

Defense contract vulnerability

“These contracts may be suspended, canceled, or delayed, which could have an adverse impact on our revenues.” · word for word
Read the original on SEC EDGAR ↗
10 Feb 20268-K · 7.01LTM Revenue $541M; LTM Adj. EBITDA Margin 23; LTM Adj. Diluted EPS $2.23open

Figures in the filing · each found in the filing text

LTM Revenue · FY2025$541M
LTM Adj. EBITDA Margin · FY202523.0%
LTM Adj. Diluted EPS · FY2025$2.23
Read the original on SEC EDGAR ↗
10 Feb 20268-K · 2.02, 7.01Sales $137M (+9% y/y); Net income $20M (+67% y/y); Diluted EPS $0.67 (+76% y/y); Guidance: FY2026 sales $550-$580M; Adj. diluted EPS $2.30-$2.45earningsopen

Figures in the filing · each found in the filing text

Sales · Q4-2025$137M+9% y/y
Net income · Q4-2025$20M+67% y/y
Diluted EPS · Q4-2025$0.67+76% y/y
Adjusted Gross margin · Q4-202539.1%
Adjusted EBITDA margin · Q4-202523.7%
Adjusted diluted EPS · Q4-2025$0.62+24% y/y
Operating cash flow · Q4-2025$29M+16% y/y
Full Year Sales · FY2025$541M+5% y/y
Full Year Net income · FY2025$65M+16% y/y
Full Year Diluted EPS · FY2025$2.19+22% y/y

Guidance

FY2026 sales $550-$580M; Adj. diluted EPS $2.30-$2.45

CTS expects FY2026 sales of $550-$580M (midpoint $565M, +4.4% vs FY2025 $541M) and Adj. diluted EPS of $2.30-$2.45 (midpoint $2.375, +6.5% vs FY2025 $2.23), indicating continued growth and margin expansion.

Risks flagged

Transportation market sales declined 7% in FY2025, indicating cyclical weakness in that segment.

“Sales to the transportation end market decreased 7% in full year 2025.” · word for word
Read the original on SEC EDGAR ↗
26 Nov 20258-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open

Risks flagged

Departure of senior executive may cause short-term disruption, but appointment of internal candidate mitigates risk.

“Pratik Trivedi, Senior Vice President, has been appointed Chief Operating Officer (“COO”) of CTS effective December 5, 2025.” · word for word
Read the original on SEC EDGAR ↗
24 Nov 20258-K · 1.01, 1.02, 2.03Entered a material definitive agreement (acquisition, partnership, or major contract); terminated a material definitive agreement, ending a significant contractopen

Risks flagged

Debt covenant compliance risk: net leverage ratio must not exceed 3.5x (or 4.25x post-acquisition) and interest coverage must be at least 3.0x.

“Credit Agreement requires that the Company maintain a net leverage ratio of not greater than 3.5 to 1.0 and to maintain an interest coverage ratio of not less than 3.0 to 1.” · word for word
Read the original on SEC EDGAR ↗
6 Nov 20258-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)SEC ↗
28 Oct 202510-QCTS reported Q3 2025 results with 8% revenue growth driven by Aerospace & Defense, Industrial, and Medical segments, but net income declined due to higher expenses.earningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2025$143M+8% y/y
Net Income · Q3-2025$14M-24% y/y
Diluted EPS · Q3-2025$0.46-22% y/y
Gross Margin · Q3-202538.7%
Operating Cash Flow · 9M-2025$73M-1% y/y

Risks flagged

Environmental Remediation Liability

“The Company has updated its estimate of potential exposure to be between $5,970 and $8,290. We have determined that no point within this range is more likely than another and, therefore, we have recorded a loss estimate of $5,970 as of September 30, 2025.” · word for word

Transportation Market Weakness

“Transportation $58,547 for the three months ended September 30, 2025 compared to $63,031 for the three months ended September 30, 2024.”

Restructuring Charges

“Restructuring charges $280 for the three months ended September 30, 2025.”
Read the original on SEC EDGAR ↗
28 Oct 20258-K · 2.02, 7.01Sales $143M (+8% y/y); Net income $14M (-22% y/y); Diluted EPS $0.46 (-22% y/y); Guidance: FY2025 sales $535-$545M; adjusted diluted EPS $2.20-$2.25earningsopen

Figures in the filing · each found in the filing text

Sales · Q3-2025$143M+8% y/y
Net income · Q3-2025$14M-22% y/y
Diluted EPS · Q3-2025$0.46-22% y/y
Adjusted diluted EPS · Q3-2025$0.60-2% y/y
Adjusted Gross margin · Q3-202538.9%
Adjusted EBITDA margin · Q3-202523.8%
Operating cash flow · Q3-2025$29M-17% y/y

Guidance

FY2025 sales $535-$545M; adjusted diluted EPS $2.20-$2.25

Guidance updated; sales midpoint $540M, EPS midpoint $2.225; no prior guidance provided for comparison, but implied cut given Q3 results and cautious outlook.

Risks flagged

Transportation end market decline continues; -7% YoY.

“Sales to the transportation end market decreased 7%.” · word for word

EPA past cost recovery claim resulted in $4.2M charge; potential for further environmental liabilities.

“Net income was $14 million, or 9.6% of sales, including an extraordinary $4.2 million charge related to the previously disclosed EPA past cost recovery claim.” · word for word
Read the original on SEC EDGAR ↗
28 Oct 20258-K · 7.01LTM Revenue $531M; LTM Adjusted EBITDA Margin 23; LTM Adjusted Diluted EPS $2.11open

Figures in the filing · each found in the filing text

LTM Revenue · LTM$531M
LTM Adjusted EBITDA Margin · LTM23.0%
LTM Adjusted Diluted EPS · LTM$2.11

Risks flagged

Tariff and geopolitical risks

“Forward-looking statements cite tariffs on China, Canada, Mexico, and geopolitical conflicts as risk factors”

Supply chain disruption risk

“Supply chain disruptions including availability of rare earth elements, minerals and metals”
Read the original on SEC EDGAR ↗

CTS Corporation — questions

What did CTS Corporation file recently?
19 SEC filings in the last 12 months. Latest: SC 13D/A on 2026-08-05 — Gabelli-related entities filed a Schedule 13D disclosing a 5.75% passive stake in CTS Corp, with no activist intent and recent small sales.

Every figure on this page comes from CTS Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.